This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Felker, G. M. Search for Related Content PubMed PubMed Citation Articles by Felker, G. M.

Heart failure etiology and response tomilrinone in decompensated heart failure

Results from the OPTIME-CHF study

G. Michael Felker, MD^*,*, Raymond L. Benza, MD, A. Bleakley Chandler, MD, Jeffrey D. Leimberger, PhD^*, Michael S. Cuffe, MD^*, Robert M. Califf, MD^*, Mihai Gheorghiade, MD, Christopher M. O’Connor, MD^* OPTIME-CHF Investigators

^* Duke Clinical Research Institute, Durham, North Carolina, USA
University of Alabama-Birmingham, Birmingham, Alabama, USA
University Hospital, Augusta, Georgia, USA
Northwestern University Medical Center, Chicago, Illinois, USA

View larger version (18K): [in a new window]   Figure 1 Kaplan-Meier survival curves to 60 days by heart failure etiology and treatment assignment.

View larger version (15K): [in a new window]   Figure 2 Composite end point of death + rehospitalization by heart failure etiology and treatment assignment. p = 0.01 for etiology-treatment interaction.